Phase III results in patients with suspected cardiac amyloidosis were presented at the European Society of Cardiology (ESC) Congress 2026 and simultaneously published in The Journal of the American...
Presentations include investigational late-breaking KERENDIA ® (finerenone) data in chronic kidney disease (CKD), including a pooled analysis from studies in patients with and without diabetes...
Expanded authorization introduces a treatment option for women experiencing moderate to severe hot flashes and/or night sweats caused by adjuvant endocrine therapy (AET) related to breast cancer ...
New Formula Delivers Daily Nutritional Support for Hair, Skin and Nails* Key Facts One A Day® Women's Multi Gummy vitamins...
New research by Economist Enterprise, supported by Bayer, highlights the potential of self-care to become a more integrated component of modern health systems The research underscores...
Henry Ford Health selected as one of only four U.S. academic health systems in Bayer’s strategic research network
Funding supports commercialization and sales growth expansion, targeting hundreds of new farms in the next 12 months Autonomy technology is designed to lower capital expenditures and...
Bayer’s first academic medical center alliance for clinical trial collaboration is designed to accelerate medical discovery and expand patient access to investigational therapies
One A Day®, the multivitamin and supplement brand from Bayer, has partnered with country superstar and five time Entertainer of the Year Luke Bryan to launch a limited edition multivitamin bottle featuring...
Advances key component of Crop Science division’s Five-Year Framework strategy Reinforces commitment to delivering trusted Roundup ® brands and glyphosate...